99 results
Page 4 of 5
8-K
EX-99.1
c5fmi6067fwu6nupr 3x
11 May 20
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
366 a8kuf9oinhns4
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
8-K
EX-99.1
ohh8aafnqt4u45es4r
30 Mar 20
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
9:01am
8-K
EX-99.1
kxusx
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
EX-99.1
9y4a8pqb
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-99.1
fsc5 22bz
4 Nov 19
Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
cs9uyh1qacxq6gmfo8t3
14 Aug 19
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
12:00am
8-K
EX-99.1
7wtjadufq18byr7nl o5
3 Jun 19
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
8:45am
8-K
EX-99.1
f1k1y6j
13 May 19
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
3byo9ol3 7k
12 Mar 19
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
9:16am
DEFM14A
cc9ylu
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
04zsf8 ag
11 Dec 18
Preliminary proxy related to merger
5:23pm
8-K
EX-99.1
m0hhiwol6 wt0
14 Nov 18
Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-10.9
c4b15
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm